GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 11.398
AS - Asia 6.963
EU - Europa 1.776
Continente sconosciuto - Info sul continente non disponibili 651
SA - Sud America 631
AF - Africa 145
OC - Oceania 17
Totale 21.581
Nazione #
US - Stati Uniti d'America 10.290
TR - Turchia 2.410
SG - Singapore 1.809
CN - Cina 1.697
CA - Canada 1.016
IT - Italia 1.015
BR - Brasile 493
VN - Vietnam 385
EU - Europa 177
HK - Hong Kong 169
IN - India 131
FR - Francia 129
DE - Germania 100
IE - Irlanda 99
GB - Regno Unito 91
BD - Bangladesh 59
MX - Messico 54
AR - Argentina 49
FI - Finlandia 48
PK - Pakistan 46
ZA - Sudafrica 44
RU - Federazione Russa 42
ES - Italia 39
PL - Polonia 39
IQ - Iraq 37
ID - Indonesia 36
JP - Giappone 31
NL - Olanda 31
SC - Seychelles 30
IL - Israele 29
UA - Ucraina 27
PH - Filippine 20
MA - Marocco 19
EC - Ecuador 18
RO - Romania 18
SA - Arabia Saudita 18
SE - Svezia 17
CO - Colombia 16
CL - Cile 15
LT - Lituania 14
AU - Australia 13
TN - Tunisia 13
PY - Paraguay 11
VE - Venezuela 11
UZ - Uzbekistan 10
EG - Egitto 8
KE - Kenya 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
NP - Nepal 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
JO - Giordania 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
UY - Uruguay 6
AL - Albania 5
BB - Barbados 5
BO - Bolivia 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
PT - Portogallo 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
GR - Grecia 4
HU - Ungheria 4
JM - Giamaica 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BE - Belgio 3
BS - Bahamas 3
CI - Costa d'Avorio 3
DZ - Algeria 3
ET - Etiopia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
MU - Mauritius 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
AD - Andorra 1
AM - Armenia 1
Totale 21.087
Città #
Kocaeli 2.103
San Mateo 1.619
Dallas 1.202
San Jose 1.139
Toronto 961
Ashburn 777
Rome 720
Council Bluffs 693
Beijing 496
Singapore 470
Wilmington 465
Houston 431
Santa Clara 402
Phoenix 371
Princeton 330
Lawrence 322
Chandler 210
Hong Kong 156
Ho Chi Minh City 139
Seattle 132
Fairfield 129
Los Angeles 121
Shanghai 102
Woodbridge 101
Hanoi 88
Guangzhou 67
Cambridge 55
São Paulo 47
Brooklyn 44
New York 42
Helsinki 37
Dublin 36
Chicago 33
Shenzhen 33
Redwood City 31
Islamabad 30
Mexico City 29
Frankfurt am Main 27
Netanya 27
The Dalles 27
Tokyo 27
Warsaw 27
Johannesburg 24
Columbus 23
Chennai 22
Orem 22
Boston 20
Da Nang 20
London 20
Milan 18
Atlanta 17
Montreal 17
Munich 17
Saint Petersburg 17
Washington 17
Haiphong 16
Wuhan 16
Baghdad 15
Quanzhou 15
Redmond 15
Rio de Janeiro 15
Xi'an 14
Buffalo 13
Jiaxing 13
Mumbai 13
Amsterdam 12
Queens 12
Rui'an 12
Ankara 11
Belo Horizonte 11
Charlotte 11
Nanjing 11
Pune 11
Roubaix 11
Wuxi 11
Bandung 10
Curitiba 10
Kyiv 10
Philadelphia 10
San Francisco 10
Stockholm 10
Hyderabad 9
Pesaro 9
Tashkent 9
Thái Nguyên 9
Turku 9
Bari 8
Bexley 8
Cleveland 8
Dhaka 8
Dongyang 8
Jinhua 8
Paris 8
Riyadh 8
Taizhou 8
Wroclaw 8
Basra 7
Biên Hòa 7
Jakarta 7
Nantong 7
Totale 15.023
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 145
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 137
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 131
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 129
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 128
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 115
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 114
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 113
Activation of blood coagulation in breast cancer - relationship to clinical outcome 109
Aging: an important risk factor in chemotherapy-associated vascular diseases 108
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 107
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 106
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 104
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 100
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 99
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 99
A NOVEL NONSENSE MUTATION IN KRAS GENE 98
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 98
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 97
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 96
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 96
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 93
Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression 91
Age-Dependent Levels of Protein Kinase Cs in Brain: Reduction of Endogenous Mechanisms of Neuroprotection 91
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 90
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 89
Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer 88
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 87
Age-related reduction of cerebral ischemic preconditioning: myth or reality? 86
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 86
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 85
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 84
CLINICAL-EVALUATION OF SERUM TUMOR-ASSOCIATED GLYCOPROTEIN-72 AS A NOVEL TUMOR-MARKER FOR COLORECTAL-CANCER PATIENTS 83
"Proteomineering" or not? The debate on biomarker discovery in sera continues 83
Sentinel lymphadenectomy in cutaneous melanoma 82
“Personal and sensitive data in the e-health-IoT universe” 82
MAINTENANCE OF EXPRESSION OF TUMOR-ANTIGENS IN 3-DIMENSIONAL INVITRO HUMAN TUMOR GEL-SUPPORTED HISTOCULTURE 80
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 80
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 79
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 79
BRCA1 and BRCA2 mutations in central and southern Italian patients 79
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers 79
Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs 78
Role of interleukin-6 in the diagnosis of acute aortic dissection 77
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 77
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 77
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 77
VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients 77
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 76
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 76
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 76
Genetic instability in superficial bladder cancer and adjacent mucosa: An interphase cytogenetic study 76
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 75
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 75
Tumor markers as targets for selective diagnostic and therapeutic procedures 75
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 75
Machine learning approach to predict medication overuse in migraine patients 75
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 74
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 74
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation 74
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 74
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 74
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 73
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 73
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 73
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients 73
Protective Effect of Antioxidants in Nitric Oxide/COX-2 Interaction during Inflammatory Pain: The Role of Nitration 73
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 72
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 72
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 72
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 72
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 71
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 71
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 71
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 71
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 71
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 71
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 71
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 71
Artificial intelligence for cancer-associated thrombosis risk assessment 71
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 71
Complex variant Philadelphia translocation involving the short arm of chromosome 9 in a case of chronic myeloid leukemia 70
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 70
Effect of acute consumption of oolong tea on antioxidant parameters in healthy individuals 70
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 70
CA-72-4 SERUM MARKER - A NEW TOOL IN THE MANAGEMENT OF CARCINOMA PATIENTS 70
Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing 70
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 69
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 69
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 69
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 69
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 69
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 69
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients 69
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 69
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 69
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 69
In vitro interactions between blood platelets and human colorectal tumor cells 68
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 68
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 68
Totale 8.294
Categoria #
all - tutte 194.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.160 0 0 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/20267.133 534 751 922 475 517 835 1.069 438 585 829 97 81
2026/20272.079 93 874 1.112 0 0 0 0 0 0 0 0 0
Totale 21.581